EMZYDA Trademark

Trademark Overview

On Thursday, February 28, 2019, a trademark application was filed for EMZYDA with the United States Patent and Trademark Office. The USPTO has given the EMZYDA trademark a serial number of 88320548. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by Global Blood Therapeutics, Inc.. The EMZYDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
emzyda

General Information

Serial Number88320548
Word MarkEMZYDA
Filing DateThursday, February 28, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Translation of Words in MarkThe wording "EMZYDA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 8, 2022SOU EXTENSION 5 GRANTED
Monday, February 28, 2022SOU EXTENSION 5 FILED
Tuesday, March 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, August 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 17, 2021SOU EXTENSION 4 GRANTED
Tuesday, August 17, 2021SOU EXTENSION 4 FILED
Tuesday, August 17, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021SOU EXTENSION 3 GRANTED
Friday, February 26, 2021SOU EXTENSION 3 FILED
Friday, February 26, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020SOU EXTENSION 2 GRANTED
Tuesday, September 1, 2020SOU EXTENSION 2 FILED
Tuesday, September 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2020SOU EXTENSION 1 GRANTED
Monday, January 27, 2020SOU EXTENSION 1 FILED
Monday, January 27, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 30, 2019ASSIGNED TO LIE
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, May 9, 2019ASSIGNED TO EXAMINER
Wednesday, March 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 4, 2019NEW APPLICATION ENTERED

Related Keywords

emzyda treatment preparations pharmaceutical hypoxic conditions disease hypoxemic such hematological disorders